Fier d'assister au congrès virtuel ISPOR 2021!

PeriPharm est fier d’assister et de présenter certaines collaborations au congrès virtuel ISPOR 2021 qui a eu lieu en mai 2021.

• Lachaine J, Jain MD, Bibeau J, Marino JP, Ball G. Cost Associated with Implementation of CAR T-Cell Therapy for the Management of Hematologic Cancers in Canada. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) (pp PCN191), May 2021, Montreal, Canada (virtual meeting) link
• Mathurin K, Castonguay A, Parison D, Rahal Y, Lachaine J, Beauchemin C. Economic Impact of Originator-to-Biosimilar Non-Medical Switching on Health Care Resource Utilization in Rheumatic Patients in Quebec, Canada. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) (pp PBI10), Montreal, Canada (virtual meeting) link
• Hillhouse E, Bibeau J, Parison D, Rahal Y, Lachaine J, Beauchemin C. Economic Impact of an Originator-to-Biosimilar Non-Medical Switch in the Real-World Setting- A Systematic Literature Review. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) (pp PBI8), Montreal, Canada (virtual meeting) link